Results 161 to 170 of about 178,517 (322)

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia

open access: yesCancer Reports
Background Immune thrombocytopenia (ITP) is an acquired autoimmune disease characterised by low platelet count. Treatment discontinuation or heterogeneity in the pathogenesis of ITP heightens the occurrence of relapsed or refractory ITP.
Bingjie Ding   +7 more
doaj   +1 more source

Assessment of ethnic differences in pharmacokinetics and clinical responses of acalabrutinib between Chinese and White patients with B‐cell malignancies

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 2008-2019, July 2025.
Abstract Aims The aim of this study was to assess differences between Chinese and White patients in pharmacokinetics (PK) of, and clinical response to, acalabrutinib and its pharmacologically active major metabolite, ACP‐5862, to support recommended dosing in Chinese patients with B‐cell malignancies.
Tingting Yao   +5 more
wiley   +1 more source

Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus

open access: yesEMBO Molecular Medicine, 2015
Transplant recipients on calcineurin inhibitors are at high risk of invasive fungal infection. Understanding how calcineurin inhibitors impair fungal immunity is a key priority for defining risk of infection.
Susanne Herbst   +10 more
doaj   +1 more source

Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma

open access: yesMedComm, Volume 6, Issue 7, July 2025.
1. Genetic subtypes based on molecular subtyping correlated with prognosis in DLBCL. 2. Integrated genetic subtype‐based IPI model revealed prognostic discrimination. 3. New four‐category risk model defined for integrated model showed diverse prognosis.
Lan Mi   +14 more
wiley   +1 more source

Advancing Design Strategy of PROTACs for Cancer Therapy

open access: yesMedComm, Volume 6, Issue 7, July 2025.
A comprehensive update on the PROTAC design, and highlighting the role of artificial intelligence in the PROTAC design for cancer therapy. ABSTRACT Proteolysis targeting chimeras (PROTACs) have emerged as a groundbreaking class of anticancer therapeutics.
Hang Luo   +5 more
wiley   +1 more source

Role of the PHTH Module in Protein Substrate Recognition by Bruton's Agammaglobulinemia Tyrosine Kinase [PDF]

open access: hybrid, 2001
William E. Lowry   +4 more
openalex   +1 more source

Distinct Cytokine Profiles in Chronic Spontaneous Urticaria Refractory to H1‐Antihistamines Compared to Healthy Controls

open access: yes
Clinical &Experimental Allergy, EarlyView.
Young‐Min Ye   +4 more
wiley   +1 more source

Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs

open access: yesPediatric Blood &Cancer, Volume 72, Issue 7, July 2025.
ABSTRACT Pediatric immune thrombocytopenia (ITP) is associated with a multifaceted burden on children and their parents/caregivers due to bleeding, fatigue, activity restrictions, and psychological distress. Most children recover within 12 months, but up to 30% develop chronic ITP.
Joana Azevedo   +4 more
wiley   +1 more source

The role of miRNA-4516 in regulating Bruton's tyrosine kinase expression and colorectal cancer progression in a sample of Iraqi population

open access: yesJournal of Biological Research
Considering the second-highest global death rate, Colorectal Cancer (CRC) is the second most prevalent form of cancer in women and the third most frequent cancer type in men.
Ahmed Sadoon Hassain   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy